Detection of misfolded Aß oligomers for sensitive biochemical diagnosis of Alzheimer's disease.
Cell Rep
; 7(1): 261-8, 2014 Apr 10.
Article
em En
| MEDLINE
| ID: mdl-24656814
ABSTRACT
Alzheimer's disease (AD) diagnosis is hampered by the lack of early, sensitive, and objective laboratory tests. We describe a sensitive method for biochemical diagnosis of AD based on specific detection of misfolded Aß oligomers, which play a central role in AD pathogenesis. The protein misfolding cyclic amplification assay (Aß-PMCA), exploits the functional property of Aß oligomers to seed the polymerization of monomeric Aß. Aß-PMCA allowed detection of as little as 3 fmol of Aß oligomers. Most importantly, using cerebrospinal fluid, we were able to distinguish AD patients from control individuals affected by a variety of other neurodegenerative disorders or nondegenerative neurological diseases with overall sensitivity of 90% and specificity of 92%. These findings provide the proof-of-principle basis for developing a highly sensitive and specific biochemical test for AD diagnosis.
Texto completo:
1
Base de dados:
MEDLINE
Assunto principal:
Peptídeos beta-Amiloides
/
Doença de Alzheimer
Tipo de estudo:
Diagnostic_studies
/
Observational_studies
Limite:
Adult
/
Aged
/
Aged80
/
Humans
/
Middle aged
Idioma:
En
Ano de publicação:
2014
Tipo de documento:
Article